Voting Rights Announcements | 21 August 2009 20:25
STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)
Release of a Voting Rights announcement, transmitted by DGAP - a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 19 August 2009, that on 12 August 2009 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 went below the threshold of 10% and that the
percentage of voting rights on that day amounted to 9.979% (1,140,576
shares). These voting rights are in their entirety attributable to
Threadneedle Asset Management Holdings Limited pursuant to § 22 para. 1
sent. 1 No. 6, sent. 2 and sent. 3 WpHG. These voting rights are held by
subfunds of Threadneedle Investment Funds ICVC and other funds.
Threadneedle Asset Management Holdings SARL, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 19 August 2009, that on 12 August 2009 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 went below the threshold of 10% and that the
percentage of voting rights on that day amounted to 9.979% (1,140,576
shares). These voting rights are in their entirety attributable to
Threadneedle Asset Management Holdings SARL pursuant to § 22 para. 1 sent.
1 No. 6, sent. 2 and sent. 3 WpHG. These voting rights are held by subfunds
of Threadneedle Investment Funds ICVC and other funds.
Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to § 21 sec. 1 WpHG on 19 August 2009, that on 12 August 2009 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 went below the threshold of 10% and that the
percentage of voting rights on that day amounted to 9.979% (1,140,576
shares). These voting rights are in their entirety attributable to
Ameriprise Financial, Inc. pursuant to § 22 para. 1 sent. 1 No. 6, sent. 2
and sent. 3 WpHG. These voting rights are held by subfunds of Threadneedle
Investment Funds ICVC and other funds.
21.08.2009 Financial News transmitted by DGAP
----------------------------------------------------------------------
Language: English
Issuer: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Internet: www.stratec-biomedical.de
End of News DGAP News-Service
---------------------------------------------------------------------------